This statistic depicts the estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020. In 2020, the cardiovascular disease drugs market in South Korea is forecasted to be worth around 4.29 trillion South Korean won.
Estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020 (in trillion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Anti-cancer drugs estimated market size in South Korea 2014-2020
- Premium Statistic Anti-diabetics estimated market size in South Korea 2014-2020
- Premium Statistic Cholesterol drugs estimated market size in South Korea 2014-2020
- Basic Statistic Cardiovascular system pharmaceutical consumption in Belgium 2008-2021
- Basic Statistic Dispensed mineral supplements in the Netherlands 2014-2022
- Premium Statistic Price increase select geriatric drugs in the U.S. in 2020
- Basic Statistic Price increase of brand drugs mostly used by US seniors by use and competition 2020
- Basic Statistic Leading drugs for hypertension and heart failure in England by item number 2022
- Basic Statistic Number of users of hypertension medicine in Sweden 2022, by age and gender
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2022
About the region
10
- Premium Statistic Most common prescription drugs for prostatic hyperplasia South Korea 2016
- Premium Statistic BPH outpatient prescription medicine sales in South Korea 2016, by age group
- Premium Statistic Clock & watch market size South Korea 2013-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Biopharmaceutical market size in South Korea 2012-2022
- Premium Statistic Processed food market size in South Korea 2012-2022
Selected statistics
6
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
- Basic Statistic Diabetes pharmaceutical consumption rate in Norway 2011-2022
- Premium Statistic Sales volume of drugs for the cardiovascular system in Italy 2022, by type
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
- Premium Statistic Sales of pharmaceutical drugs Thailand 2021, by type
- Basic Statistic Cardiovascular system daily pharmaceutical consumption in Iceland 2009-2022
- Basic Statistic Dispensed Parkinson medicines in the Netherlands 2014-2022
- Premium Statistic TCM turnover in China 2010-2022
- Basic Statistic Revenue of pharmacy market in Sweden 2013-2022
- Basic Statistic Level 1 ATC therapy classes by share of total public drug costs in Canada 2021/2022
Related statistics
10
- Premium Statistic Herbal raw material market size in South Korea 2012-2022
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Busan and Gyeongnam South Korea 2020
- Premium Statistic Drugs for Alzheimer's disease sales in South Korea 2011-2016
- Premium Statistic Ultrasound bone densitometer market size in South Korea 2010-2015
- Premium Statistic Distribution of incrementally modified drugs approved South Korea 2009-2016, by type
- Premium Statistic South Korea's diabetes therapy and drug delivery market size 2014-2023
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic Traditional medicine industry sales in South Korea 2021, by sector
Further related statistics
9
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Leading European medtech countries based on market capitalization 2014
- Global pharmaceutical pipeline by therapy area 2013-2017
- Leading banks in the Middle East in 2023, by brand value
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Leading European medtech countries based on market capitalization 2014
- Global pharmaceutical pipeline by therapy area 2013-2017
- Leading banks in the Middle East in 2023, by brand value
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
Datamonitor. (March 31, 2015). Estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020 (in trillion South Korean won) [Graph]. In Statista. Retrieved March 28, 2024, from https://www.statista.com/statistics/779287/south-korea-cardiovascular-disease-drugs-estimated-market-size/
Datamonitor. "Estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020 (in trillion South Korean won)." Chart. March 31, 2015. Statista. Accessed March 28, 2024. https://www.statista.com/statistics/779287/south-korea-cardiovascular-disease-drugs-estimated-market-size/
Datamonitor. (2015). Estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020 (in trillion South Korean won). Statista. Statista Inc.. Accessed: March 28, 2024. https://www.statista.com/statistics/779287/south-korea-cardiovascular-disease-drugs-estimated-market-size/
Datamonitor. "Estimated Size of The Cardiovascular Disease Drugs Market in South Korea from 2014 to 2020 (in Trillion South Korean Won)." Statista, Statista Inc., 31 Mar 2015, https://www.statista.com/statistics/779287/south-korea-cardiovascular-disease-drugs-estimated-market-size/
Datamonitor, Estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020 (in trillion South Korean won) Statista, https://www.statista.com/statistics/779287/south-korea-cardiovascular-disease-drugs-estimated-market-size/ (last visited March 28, 2024)
Estimated size of the cardiovascular disease drugs market in South Korea from 2014 to 2020 (in trillion South Korean won) [Graph], Datamonitor, March 31, 2015. [Online]. Available: https://www.statista.com/statistics/779287/south-korea-cardiovascular-disease-drugs-estimated-market-size/